Allison DeAngelis authored an article, featuring Vibe Bio CEO, Alok Tayi, on ‘decentralized science’ which seeks to upend drug industry financing. The article detailed Alok’s journey to founding Vibe Bio.
“The experience stuck with Tayi, who is a scientist and entrepreneur, and led him to co-found a new organization that’s designed to allow patients, scientists, and other experts to have a say in financing rare disease drug development. The organization, Vibe Bio, launched on Wednesday with $12 million in seed funding.”
